FindTrial
Sign In

Effect of Direct-acting Antiviral Drugs on Erectile Function

Effect of Direct-acting Antiviral Drugs on Erectile Function Among Hepatitis c Patients

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03444272
Enrollment
105
Registered
2018-02-23
Start date
2018-01-01
Completion date
2022-12-31
Last updated
2020-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatitis C

Brief summary

Effect of direct-acting antiviral drugs on erectile function

Detailed description

Effect of direct-acting antiviral drugs on erectile function in HCV patients

Interventions

DRUGSofosbuvir and Daklatasuvir

HCV Treatment (Sofosbuvir and Daklatasuvir)

Sponsors

Benha University
CollaboratorOTHER
Sherief Abd-Elsalam
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* HCV infected patients * Male

Exclusion criteria

* HCC * Age below 18 years

Design outcomes

Primary

MeasureTime frameDescription
Number of patients with improved erectile functions6 monthsNumber of patients with improved erectile functions

Countries

Egypt

Contacts

Primary ContactSherief Abd-Elsalam, MD
sheriefabdelsalam@yahoo.com00201095159522
Backup ContactSherief Abd-Elsalam
sheriefabdelsalam@yahoo.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026